Introduction
A multifaceted approach to the investigation of genetic regulation of development will be required to elucidate the specific etiologies of congenital malformations. Transgenic insertion and targeted disruption of genes in mice have resulted in a rapid advance in our understanding of many developmental processes. However, these strategies often result in embryonic lethality before critical periods of organ development, and the cause of lethality is often secondary to a primary defect in cardiovascular development.
1,2 Therefore, specific gene manipulation techniques that provide temporal regulation as well as tissue-and organ-specific gene expression are needed to study basic developmental mechanisms at later stages of morphogenesis. 3 To date, variables influencing exogenous gene transduction during in utero development have not been well delineated.
The majority of published studies documenting gene expression in utero have utilized direct administration of transgene to the embryo and have focused on gene transduction in the epithelium of the lung or the embryonic liver. Expression of transgene in fetal lungs via tracheal or amniotic fluid administration of adenovirus or retrovirus has been evaluated in sheep and rodents with vari-able results. In sheep, transient transgene expression with immune stimulation was found, and in mice and rats a range of organ expression patterns were seen ranging from no expression to expression seen in the epithelium of lung, gastrointestinal tract and amniotic membrane. [4] [5] [6] [7] [8] Liver-directed gene transfer studies have included direct administration of retroviral vectors by injection into fetal rat livers resulting in transduction of proliferating hematopoietic cells, and cardiac administration of adenovirus resulting in transient liver transgene expression in fetal rabbits. [9] [10] [11] Although not delivered directly to the embryo, administration of vectors intravascularly to the pregnant mother has been reported to result in embryonic gene transfer: Kass-Eisler et al 12 reported injecting pregnant female rats with a recombinant adenovirus at 12 days gestation and found low levels of transgene expression 1 day after birth. Tsukamoto et al 13 injected expression plasmids complexed to lipopolyamine into the tail veins of pregnant mice and found the gene present in pups up to 1 month after birth. Other methods of fetal gene transfer have included: ex vivo retrovirus-transduced fetal hematopoietic cells which were re-infused in the donor fetus with intermittent detection of transgene activity post-natally; 14 intraperitoneal, retrovirus injection into fetal and adult rats; 15 intraplacental injection at a single developmental time-point; 16 and introduction of normal fetal liver cells or retrovirus-transduced cultured placental cells into the fetal placenta. 17, 18 Only a limited number of studies have allowed for development to term and even fewer studies have assessed gene expression longer than a week following vaginal delivery. 9, 10, 14, 15 As the route and timing of administration have been found to be critical determinants of transduction efficiency in neonatal and adult rats, 12, 19, 20 these variables are likely to be influential for in utero gene transfer as well. In this study we investigated the extent of gene transduction resulting from direct intravascular injection of replication-defective adenovirus encoding the gene for ␤-gal (lacZ) driven by the CMV enhancer/promoter to the mouse embryo at several developmental stages. Following in utero gene transfer, evaluation of targeted tissues and organs was performed 1 day following injection, at birth, and at 5 weeks of age. Preferential targeting of the cardiovascular system was observed with transgene expression detected primarily in the endocardium of the heart and the endothelium of multiple organs. The pattern of gene expression was dependent on the developmental stage of the embryo at the time of virus administration. These studies suggest that the developing cardiovascular system may be particularly accessible to adenovirus-mediated gene transduction.
Results
Prenatal transgene expression following in utero adenovirus delivery To evaluate the tissue and organ distribution of adenovirus-mediated gene transduction, embryos were injected with replication-deficient adenovirus (AdCMV. LacZ) or with an equal volume of saline utilizing the yolk sac injection approach shown in Figure 1 . Histochemical analysis 24 h following adenovirus administration to day 12 embryos revealed ␤-gal expression primarily in the liver with some staining in the heart (Figure 2a ) while control (saline injected) embryos expressed no transgene activity following X-gal staining (Figure 2b ). Microscopic evaluation of 12 days post-conception (d.p.c.) adenovirus injected embryos showed ␤-gal expression in endothelial cells of the right ventricular outflow tract (16% of cells) and in hepatocytes (92% of cells, Table 1 ).
However, when embryos were injected at 13 days gestation and evaluated 1 day later (Figure 2c -f, and Figure 2d ). In addition, endothelial cells lining the rudimentary pulmonary valve, main pulmonary artery, in the periphery of the lung (Figure 2e and f) , and in the brachiocephalic vessels expressed ␤-gal. As with the 12 d.p.c. injected embryos, the entire liver (98% of cells) demonstrated intense transgene expression ( Figure 2c ) and saline injected control embryos showed no ␤-gal activity.
The most extensive gene transduction was detected in embryos injected at 15 days and evaluated 24 h later ( Figure 3) . As with embryos injected on day 13, expression was accentuated in the heart and was most prominent in the atria (see Table 1 ). In addition, expression could be easily detected in both ventricles, the descending aorta, and large and small vessels in the lung (Figure 3a 
-Gal expression is seen predominantly in the liver (×12). (b) Photograph of control, saline injected 12 d.p.c. embryo showing no ␤-gal expression (×12). (c) Photograph of embryo injected via the yolk sac vasculature at 13 days gestation then stained 24 h later with Xgal reagent; ␤-gal expression is seen in both atria, ventricles, liver and peripheral vessels (×10). (d) Magnified view of heart from embryo shown in (c). Significant staining of the atria and ventricles is seen (×40). (e) Photomicrograph of cross-section through heart; the atria show transmural expression of ␤-gal. Expression of the transgene is also seen in ventricular endocardium, cells lining the pulmonary valve, and in the aortic and pulmonary artery endothelium (×100). (f) Lung from embryo injected at 13 d.p.c. A fine reticular pattern of ␤-gal expression is seen peripherally in the developing vascular network (×20). RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; PV, pulmonary valve.
gestation (with the same number of active viral particles as earlier stage embryos), revealed minimal transduction with only a few scattered cells of the lung, liver (see Table 1 ) and paraspinal region demonstrating detectable ␤-gal activity (not shown).
Postnatal transgene expression following in utero adenovirus delivery Pups which had been injected as embryos, in utero, at 13 days gestation, expressed ␤-gal in both atria upon evaluation 1-2 days following delivery; however, this expression was attenuated when compared with embryos injected at 13 days and evaluated 24 h later (Figures 2d, 4a and Table 1 ). Both ventricles also expressed ␤-gal with the right ventricle showing slightly more expression than the left ventricle, resulting in clear demarcation of the interventricular septum. Of note, while expression was primarily detected in endothelial cells, there was also myocardial transgene expression within the atrial wall ( Figure 4b ). The endothelium of the aortic arch and brachiocephalic vessels clearly expressed the transgene (Figure 4c ), as did the endothelium of the main pulmonary artery, branch pulmonary arteries, and liver (see Table 1 ). Pups injected in utero at 13 d.p.c. and evaluated at 5 weeks of age continued to show transgene expression within the atria and only scattered expression within the ventricles (Figure 4d-f and Table 1 ). In contrast to cardiac expression 24 h after in utero injection, 5-week-old pups expressed ␤-gal in ventricular myocardial cells, as well as endocardial cells. Interestingly, while some expression was detected in the liver (4%), it was markedly attenu- ated compared with that detected in the atria of the heart where 42% of cells expressed the transgene (Figure 4e and g). In summary, from 12 d.p.c. to 15 d.p.c. a trend of increased number of transduced organs with increasing gestational age at the time of injection of recombinant adenovirus was observed (see Table 1 ). The pattern of organ expression observed depended on the developmental stage at virus administration, and was consistent between embryos injected at the same embryonic stage. A peak in intensity of ␤-gal expression in the liver and heart was seen at 13 d.p.c., while the largest number of organs expressing the transgene was seen when embryos were injected at 15 d.p.c. and evaluated by histochemical staining 24 h later. The smallest number of transduced organs was seen with injections into the largest embryos, ie 18 d.p.c. As expected, a decrease in duration of expression of the transgene over time was also observed. This decline in expression was demonstrated by comparing the embryos injected at 13 d.p.c. and evaluated 24 h later (labeled as 13 day in Table 1 ) with embryos injected at 13 d.p.c. and evaluated following delivery (13d-Term) or at 5 weeks of age (13d-5 wk). No mice were evaluated beyond 5 weeks of age.
Adenovirus receptor expression
To begin to determine if preferential transgene expression within the cardiovascular system was a reflection of an increased susceptibility to adenoviral infection by the developing vasculature, we utilized in situ hybridization to determine the distribution of the recently described primary murine adenovirus receptor (CAR) during the initial period of in utero viral injection. Abundant CAR mRNA was detected in the developing brain, liver, heart and lung at 12 d.p.c. (see Figure 5a and b). In addition to diffuse hepatic expression, there was myocardial and epicardial as well as endocardial expression in the heart, and expression in the lung appeared to be primarily localized to the developing epithelium (Figure 5c ). This pattern contrasts with the transgene expression following adenoviral delivery at 12 d.p.c. which was primarily limited to the liver with minimal expression in the heart and no expression detected in the lungs (Figure 2a) . Thus, potential for adenoviral infection as determined by adenovirus receptor expression would appear to be more diffuse than the transgene expression observed.
Development and survival
n = 2, versus 9.6-10.9 mg protein per embryo, n = 3, respectively). Therefore, while experimental manipulation had an obvious effect on embryonic viability, this effect was significantly decreased as surgical proficiency increased, and there were no deleterious effects on embryonic development detectable as a result of adenoviral infection or transgene expression.
Discussion
In order to utilize exogenous gene delivery as a strategy for genetic manipulation during morphogenesis, it is critically important to define the patterns of gene transduction and to determine the parameters which affect gene expression in utero. To our knowledge, this is the first study to delineate parameters that affect gene transduction with in utero, intravascular administration of adenoviral vectors at several stages during critical periods of mammalian organogenesis. In neonatal and adult animals, timing and route of administration have been shown to influence patterns of gene expression significantly; in the rapidly growing and developing embryo, temporal and delivery parameters would be expected to have an even greater influence, as our study confirms. Remarkable variations were observed in the patterns of transgene expression at different developmental stages. One might expect that administration of the same number of viral particles at sequential stages of embryonic development would result in the strongest expression patterns in the smallest embryos simply based on the ratio of virus to cells present (multiplicity of infection). However, intravascular administration of the same number of adenoviral particles resulted in a peak in the number of organs expressing the ␤-gal transgene at 15 d.p.c. (higher than 12 and 13 d.p.c.). In addition, a marked accentuation of reporter gene expression in the heart and cardiovascular system was observed which peaked at 13 d.p.c., was still strong at 15 d.p.c., and remained present at 5 weeks of age.
There are several possible explanations for the developmentally dependent patterns of expression we observed, including factors which might affect viral delivery or viral infection as well as intrinsic genetic a b c d e
Figure 3 Embryos injected at 15 d.p.c. (a) Posterior view of dissected mouse embryo injected in utero with adenovirus encoding lacZ via yolk sac vessels at 15 days gestation and stained with X-gal 24 h later. Transgene expression is seen throughout the lungs, liver, kidneys, adrenal glands and descending aorta (×7.5). (b) Photograph of heart showing ␤-gal expression in the atria, left more than right, and in the ventricles. The interventricular septum is identified by an absence of blue staining (×30). (c) Photomicrograph of lung reveals transgene expression in cells which morphologically appear to be endothelial cells under higher magnification (arrows) (×150). (d) Photomicrograph of liver from embryo shown in (a). Vascular endothelium and perivascular hepatocytes express the transgene (arrows) (×50). (e) Longitudinal section of kidney and adrenal gland; arrows point to cells expressing ␤-gal in the renal medulla and in the adrenal gland (×90). RA, right atrium; LA, left atrium.
regulatory elements that affect transgene expression. Regional blood flow variations during sequential developmental stages, which might affect exposure of particular tissues to the virus, provides a physiological explanation for the variable patterns of expression found in this study. Differential flow patterns have been noted in the chick embryo where altering the site of yolk sac vessel injection of india ink affected intracardiac blood flows patterns with development. 21 This type of change in patterns of blood flow could explain the differences in right and left ventricular cardiac expression seen in this study, where the right ventricle exhibited more ␤-gal expression than the left ventricle in embryos injected at 13 d.p.c., while the left ventricle had relatively more expression than the right ventricle in embryos injected at 15 d.p.c. The latter findings are consistent with an increased proportion of cardiac output being directed to the pulmonary circulation with return to the left heart during the second half of pregnancy. 22 Preferential susceptibility to adenoviral infection of cells within the cardiovascular system appears to be an improbable explanation for the results observed. To date, CAR is the only primary adenovirus receptor that has been identified in the mouse. 23 We found that the expression of this receptor was remarkably distinct from our transgene expression, and was not restricted to or accentuated in the developing cardiovascular system. Of note, strong CAR mRNA expression was seen in the brain of 12 d.p.c. embryos. The expression in the developing lung also revealed an interesting pattern of primarily airway, instead of endothelial, expression. The developmental role of this receptor is currently being studied. In addition, the expression patterns of the secondary adenoviral receptors (the ␣ v ␤ 3 and ␣ v ␤ 5 integrins 24 ) at 12 d.p.c. is quite different than the pattern of transgene expression noted in this study (data not shown). Whether yet to be identified receptors may play a role in the accentuation of vascular infection during development, remains a matter of conjecture.
Developmental variability in the activity of promoters or other regulatory elements is the most likely explanation for the patterns of expression observed. Discrepancy between infection and expression patterns could be explained by intrinsic temporal and tissue-specific modulation of the viral regulatory elements in the embryo. Concealed gene transfer following adenoviral transduc- 
c. (a) Heart from a newborn pup injected in utero via the yolk sac vessels at 13 days gestation with AdCMV.LacZ. The RV stains more darkly than the LV and the interventricular septum can be seen expressing no ␤-gal. The LA is dark blue expressing ␤-gal (×25). (b) Photomicrograph through heart shown in (a). ␤-Gal expression is seen throughout the wall of the RA, LA and cells overlying trabeculations in the RV (×50). (c) High power view of the aortic arch, head, and neck vessels. ␤-Gal expression can be clearly seen though the vessel wall as punctate blue areas (×30). (d) Heart from a 5-week-old pup injected in utero via the yolk sac vessels at 13 days gestation. Punctate ␤-gal expression is seen scattered throughout the atria and ventricles (×10). (e) Photomicrograph of atrium from heart shown in (d). ␤-Gal expression is seen in endo-and myocardial cells (×90). (f) Photomicrograph of ventricle showing myocardial cells expressing ␤-gal (×110). (g) Photograph of the cut surface of liver from a 5-week-old pup injected at 13 d.p.c. after staining with X-gal reagent. Transgene expression is evident in the blue foci (×20)
.
c. embryos. (a) Hybridization with control sense probe reveals slight background signal primarily in the liver with no other signal detected (×2.5). (b) Section hybridized with antisense probe to murine CAR. A strong signal is detected in the brain, liver, lung, heart and tail segments. The pattern of receptor expression is more widespread than transgene expression in the adenoviral injected embryos at this stage (compare with Figure 2) (×2.5). (c) High power view of area delineated by the white box in (b). A strong signal is detected in the atrium and ventricle of the heart and the liver. In the lung, the signal is clearly seen in the developing airway at this stage (×25)
. Atr, atrium; Vent, ventricle.
tion has been described in vitro where enhancer stimulation by phorbol ester unmasked ␤-gal expression demonstrating that a lack of detectable gene activity can be secondary to inefficient gene transcription despite efficient viral uptake. 25 In addition, a published study from our laboratory documented promoter-dependent variation in the tissue expression of a reporter transgene following injection of adenovirus into the early stage mouse embryo in culture (7.5-9 days); 26 CMV promoter control resulted in primarily endothelial expression while RSV control resulted in preferential expression within the myocardium. Similarly, Woo et al 16 found that the expression pattern of ␤-gal under RSV promoter control resulted primarily in myocardial cell expression when adenovirus was injected at a single developmental timepoint (12.5 d.p.c.) into the mouse placenta. Taken together, these data would suggest that developmental factors which influence both intra-embryonic blood flow and the interactions between genetic regulatory elements affect the pattern of transgene expression following in utero adenoviral gene transfer.
Patterns of prenatal gene transduction may also be influenced by species specificity, route of administration, and immune system development. In this study, the duration of expression at 5 weeks after birth following injection at 13 d.p.c. was somewhat surprising compared with other studies showing limited duration of expression. In studies performed in sheep or in rabbits, there was a significant decrease in transgene expression to undetectable levels in utero coinciding with the onset of inflammation. 5, 6, 11 In our mice, we did not see significant histological evidence of inflammation (although specific staining for inflammatory cells was not done) and transgene expression was easily detected at birth and at 5 weeks of age. Differential expression patterns between species have previously been documented in the carotid artery model of adenovirus-mediated gene transfer where rats and sheep have distinct expression patterns. 27, 28 The route of administration in the model described here was intravascular which could alter the response of humoral and cellular components of the immune system. This effect has been described with antibody administered by intravenous versus intra-tracheal routes resulting in altered patterns of distribution in mice. 29 Prolonged expression may also result from administration of adenovirus before establishment of a fully competent immune system in the mouse. Differences in adenovirus-mediated transgene expression have been seen in immature versus mature animals. Administration of adenovirus in the neonatal period has resulted in prolonged periods of detectable expression. 20 Also, neonatal mice have been shown to have a boost in transgene expression following readministration of adenovirus, whereas re-administration in adult mice resulted in no increase in expression. 30 In the mouse CD4 precursors are first identifiable at 15 days of gestation. 31 We found that administering adenovirus before 15 d.p.c. resulted in expression for at least 5 weeks post-natally. These results suggest transduction before establishment of a fully competent immune system, by intravascular administration of adenovirus, may allow for prolonged expression beyond the embryonic period. Investigation into the establishment of tolerance to adenoviral vectors is warranted.
A notable problem with the protocol described here is the technically difficult method resulting in few embryos per pregnant dam injected and the demise by 5 weeks post-natal age. The numbers presented include all animals (early and late in the development of the method) and as the technique improved, survival increased. Injecting more than four embryos in a pregnant dam resulted in increased in utero demise, likely secondary to longer exposure of the uterus resulting in desiccation and heat loss. Death of embryos and pups appeared to be a result of the technique and not due to the virus as control, saline injections and adenovirus injections resulted in the same rate of demise. Of note, the in utero survival rate described here (75%) is essentially identical to the 74% found by Woo et al 16 following intraplacental injection and a similar rate of in utero death has been described during normal, murine development. 32 A difference found in the survival rate of newborn mice between this study (40%) and that of Woo et al (67%), may have been the result of ischemia to the gut which could have occurred in the present study. On necropsy the dead animals were found to have extensive air throughout the abdomen resembling necrotizing enterocolitis in newborns. The procedure in later experiments was modified to allow injection into smaller, more peripheral yolk sac vessels and this resulted in a survival rate of 78% at 24 h and 55% at birth.
In summary, this study describes a novel strategy for exogenous gene transduction during development, in which intravascular administration of adenovirus into the mouse embryo in utero can provide temporal targeting of organ systems depending on the timing of vector delivery. This approach should allow for the study of gene regulation during development and offers the potential for investigating the feasibility of gene therapy for genetically transferred disorders and congenitally acquired defects.
Materials and methods
Virus production Recombinant adenovirus (serotype 5, E1, E3 deleted) was prepared as previously described. 33 Briefly, viral stocks were prepared by infecting 293 cells with adenovirus encoding the lacZ gene for ␤-galactosidase controlled by the CMV enhancer/promoter. Following purification, plaque titration was performed. Viral stocks were stored frozen in 3% sucrose and diluted 1:2 with cold, sterile, phosphate-buffered saline immediately before use.
Yolk sac vessel injections
Pregnant CD-1 mice (Charles River, Portage, MI, USA) of 12, 13, 15 and 18 d.p.c. were anesthetized with an intraperitoneal injection of avertin (1.5 ml/100 g body weight). 34 The abdomen of each pregnant dam was shaved, a 15 mm (1.5 cm) vertical incision was made through the abdominal wall and peritoneum, and the uterus exposed. The yolk sac vessels of individual embryos were visualized under a Nikon (Tokyo, Japan) SMZ-U dissecting scope (Figure 1) , and using fine microscissors (Roboz, Rockville, MD, USA) a small (approximately 2 mm) hysterotomy was made to expose a peripheral yolk sac vessel (Figure 1b) . Using a 33-gauge needle (Hamilton, Reno, NV, USA) attached by tubing to a 2 cm 3 glass syringe filled with mineral oil (embryo tested, Sigma, St Louis, MO, USA) placed on a syringe pump (KD Scientific, Boston, MA, USA), 10 to 20 l of diluted, recombinant adenovirus (2-4 × 10 10 plaque forming units per embryo) encoding the lacZ gene driven by the CMV enhancer/promoter were injected into a peripheral yolk sac vessel of the embryo (Figure 1c) . The hysterotomy was closed with one to two interrupted 7-0 polypropylene stitches. The procedure was repeated on up to four embryos per pregnant female mouse. The abdomen of the female mouse was closed with running 5-0 polyglactin suture and the skin was closed with wound clips. The animal recovered in a warm cage. For prenatal analysis, the pregnant dams were killed 24 h after the procedure by cervical dislocation and the embryos analyzed as described below. For postnatal analysis, the pregnancies were allowed to progress through normal vaginal delivery and neonatal or 5-weekold pups were killed by cervical transection or dislocation and analyzed. One hundred and twelve embryos were injected: 20 embryos were injected at 12 and 15 d.p.c., eight embryos were injected at 18 d.p.c., and 64 embryos were injected at 13 d.p.c. to allow for evaluation at 24 h, birth and 5 weeks post-natally. All animal procedures conformed to the NIH Guide for the Care and Use of Laboratory Animals.
Prenatal analysis of transgene expression
Twenty-four hours after injection embryos were analyzed for ␤-gal expression by histochemistry, and development was assessed by morphometry and total protein analysis. Embryos were either frozen at −70°C or fixed in 4% paraformaldehyde for 20 min then stained with X-gal reagent (5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside) at 4°C overnight. Experimental and control animals or tissues were photographed, processed by dehydration through an ethanol gradient, and embedded in paraffin; 8 micron sections were counter-stained with eosin and examined for ␤-gal expression. The degree of gene transduction was determined by averaging the number of blue (␤-gal) expressing cells per total number of cells for 10 randomly chosen high power fields per specimen using a Phase 3 Imaging System (Glen Mills, PA, USA). For cardiac chambers, the average included equal numbers of sections from both left and right sided chambers (except for 12 day where only cells in the right ventricle were included). For liver, heart, lung, kidney, adrenal and gut, all cell types were counted. For great vessels, sections were chosen which included the lumen, and only endothelial cells from five high power fields were counted. Total protein analysis (BCA protein assay; Pierce, Rockford, IL, USA) was performed on embryos frozen 24 h after yolk sac vessel injection at 13 d.p.c. with adenovirus and on uninjected 14 d.p.c. embryos for comparison.
Postnatal analysis of transgene expression Tissues (lung, heart, liver, gut, kidneys and adrenals) from newborn (1-to 2-day-old) and 5-week-old pups which had been injected in utero at 13 d.p.c. were removed en bloc, fixed, histochemically stained, and processed for histology as described for whole embryos above.
In situ hybridization for coxsackievirus-adenovirus receptor To determine if transgene expression patterns could be explained by adenoviral receptor distribution, sections of embryos at 12 d.p.c. were probed with S 35 -labeled sense and antisense riboprobes to the entire coding region of the murine coxsackievirus-adenovirus receptor (CAR) 23, 35 using standard techniques. 36 Briefly, embryos were dissected free of extra-embryonic tissues, fixed in 4% paraformaldehyde, dehydrated through a series of ethanol gradients, and embedded in paraffin. Seven micron sections were hybridized with sense and antisense S 35 -labeled riboprobes generated from plasmid containing the coding sequence of the receptor. Hybridization was performed overnight (16 h) at 50°C, slides were washed under high stringency conditions (4 × SSC and 50% formamide/2 × SSC) and films were exposed for 2 weeks.
